A scoping review of healthcare effectiveness data and information set (HEDIS) substance use disorder measures

对医疗保健效果数据和信息集 (HEDIS) 物质使用障碍指标的范围界定综述

阅读:1

Abstract

INTRODUCTION: : There is a need to assess the delivery of interventions to improve substance use disorder (SUD) treatment, as measured by the Healthcare Effectiveness Data and Information Set (HEDIS®) metrics. The goal was to characterize published articles reporting HEDIS® SUD measures and recommend future work on applying and investigating SUD HEDIS® metrics and their effect on SUD treatments. MATERIALS AND METHODS: The PRISMA-ScR scoping review protocol was used to find published work and investigate the most common reported baseline characteristics, HEDIS® metric outcomes, and knowledge gaps. Peer-reviewed papers available through PubMed, Academic Search Premier, Elsevier/ScienceDirect, and Medline were searched up to August 14, 2022. RESULTS: : Twenty-eight articles were included after removing 92 duplications. Twenty-five articles were retrospective cohort studies, two were RCTs, and there was a mixed-method study. SUD metrics were studied in diverse settings, including ED, primary care, mental health care, and SUD specialty care. Twenty-seven papers utilized the Initiation and Engagement of Substance Use Disorder Treatment (IET) measure, and 13 had similar data sources, study populations, and authors. Eight papers presented IET results by substance used, primarily alcohol, cannabis, and opioids. CONCLUSIONS: : More research is needed on the HEDIS® SUD metrics and their usefulness in informing SUD prevention and treatment, policy, and public health outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。